Novartis Ag (NVS) Net Margin (QoQ) (2009 - 2023)
Novartis Ag (NVS) Net Margin (QoQ) (2009 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.66 Bn | 632.90 Bn | 17.26 Bn |
| 2 | AbbVie | 469.84 Bn | 463.27 Bn | 12.70 Bn |
| 3 | Merck | 378.23 Bn | 371.09 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.01 Bn | 295.32 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.57 Bn | 253.67 Bn | 12.86 Bn |
| 6 | Amgen | 237.36 Bn | 223.37 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 183.27 Bn | 180.09 Bn | 6.22 Bn |
| 8 | Pfizer | 160.74 Bn | 149.04 Bn | 10.94 Bn |
| 9 | Gsk | 105.88 Bn | 101.72 Bn | 8.24 Bn |
| 10 | Sanofi | 55.28 Bn | 47.90 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1,534.00 |
| Sep 30, 2023 | -22,810.00 |
| Jun 30, 2023 | 40,888.00 |
| Mar 31, 2023 | -19,000.00 |
| Dec 31, 2022 | 13,063.00 |
| Sep 30, 2022 | -38,852.00 |
| Jun 30, 2022 | -1.32 Bn |
| Mar 31, 2022 | 1.32 Bn |
| Dec 31, 2021 | 463,858.00 |
| Sep 30, 2021 | -478,899.00 |
| Jun 30, 2021 | -498.23 Mn |
| Mar 31, 2021 | 498.24 Mn |
| Dec 31, 2020 | -756.34 Mn |
| Sep 30, 2020 | 756.31 Mn |
| Jun 30, 2020 | 39,307.00 |
| Mar 31, 2020 | -2.75 Mn |
| Dec 31, 2019 | 2.59 Mn |
| Sep 30, 2019 | 124,322.00 |
| Jun 30, 2019 | 22,481.00 |
| Mar 31, 2019 | -3.43 Mn |